Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-PMP22 Antibody (R2B93)

Catalog #:   RHF86901 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: WB
Accession: Q01453
Overview

Catalog No.

RHF86901

Species reactivity

Human, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

WB: 1:1000-1:2000

Target

GAS-3, GAS3, PMP22, Peripheral myelin protein 22, PMP-22, Growth arrest-specific protein 3

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q01453

Applications

WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R2B93

Data Image
  • Western blot
    All lanes use the Antibody at 1:1K dilution for 1 hour at room temperature.
  • Western blot
    Western blot analysis of PMP22 expression in 293T cell lysate.
References

Influence of Constipation in the Behavior of Circulating Alpha- and Beta-CGRP Levels in Chronic/High-Frequency Migraine Patients After CGRP Monoclonal Antibodies., PMID:40427078

Deep Intraclonal Analysis for the Development of Vaccines against Drug-Resistant Klebsiella pneumoniae Lineages., PMID:39337325

Cervical Cancer Evades the Host Immune System through the Inhibition of Type I Interferon and CXCL9 by LIF., PMID:39078728

Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC study., PMID:38323742

RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine., PMID:38270379

Systemic therapies in hepatocellular carcinoma: A revolution?, PMID:38267015

Potential Predictors of Response to CGRP Monoclonal Antibodies in Chronic Migraine: Real-World Data., PMID:37874459

Myelin barrier breakdown, mechanical hypersensitivity, and painfulness in polyneuropathy with claudin-12 deficiency., PMID:37527762

The systemic inhibition of the terminal complement system reduces neuroinflammation but does not improve motor function in mouse models of CMT1A with overexpressed PMP22., PMID:36926597

Epithelial membrane protein 2 (EMP2): A systematic review of its implications in pathogenesis., PMID:36455339

miR-375 upregulates lipid metabolism and inhibits cell proliferation involved in chicken fatty liver formation and inheritance via targeting recombination signal binding protein for immunoglobulin kappa J region (RBPJ)., PMID:36410068

The male external urethral sphincter is autonomically innervated., PMID:33131096

FGF21 impedes peripheral myelin development by stimulating p38 MAPK/c-Jun axis., PMID:32657446

PMP22 Regulates Self-Renewal and Chemoresistance of Gastric Cancer Cells., PMID:28336807

Protein Profile and Morphological Alterations in Penumbra after Focal Photothrombotic Infarction in the Rat Cerebral Cortex., PMID:27324898

Expression of neuronal and signaling proteins in penumbra around a photothrombotic infarction core in rat cerebral cortex., PMID:26531025

An n-of-one RCT for intravenous immunoglobulin G for inflammation in hereditary neuropathy with liability to pressure palsy (HNPP)., PMID:26187721

Efficiency of long-term treatment with intravenous immunoglobulins correlates with reduced autoreactive T cell responses in chronic inflammatory demyelinating polyneuropathy patients., PMID:25546800

Characterization of spinal cord glial cells in a model of hindlimb unloading in mice., PMID:25218808

Effective treatment with intravenous immunoglobulins reduces autoreactive T-cell response in patients with CIDP., PMID:25074566

Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) associated to hereditary neuropathy with liability to pressure palsies (HNPP) and revealed after influenza AH1N1 vaccination., PMID:24146347

Transmembrane protein PERP is a component of tessellate junctions and of other junctional and non-junctional plasma membrane regions in diverse epithelial and epithelium-derived cells., PMID:23689684

Pemphigus vulgaris autoantibody profiling by proteomic technique., PMID:23505434

An essential role of MAG in mediating axon-myelin attachment in Charcot-Marie-Tooth 1A disease., PMID:22940629

Rewiring integrin-mediated signaling and cellular response with the peripheral myelin protein 22 and epithelial membrane protein 2 components of the tetraspan web., PMID:21421883

Schwann cell targeting via intrasciatic injection of AAV8 as gene therapy strategy for peripheral nerve regeneration., PMID:21326330

Isolated central nervous system relapse in an adolescent with acute myelomonocytic leukemia, Charcot Marie Tooth syndrome, and paraneoplastic autoantibody., PMID:20724950

TrkB and TrkC agonist antibodies improve function, electrophysiologic and pathologic features in Trembler J mice., PMID:20553714

Entrapment in anti myelin-associated glycoprotein neuropathy., PMID:19306083

Genetically determined neuropathy (CMT 1A) accompanied by immune dysfunction: a case report., PMID:19274435

Humoral and cellular immune responses to myelin protein peptides in chronic inflammatory demyelinating polyradiculoneuropathy., PMID:19015227

Immune responses to myelin proteins in Guillain-Barré syndrome., PMID:17717020

Study of antibodies to PMP22, IL-6 and TNF-alpha concentrations in serum in a CMTX1 family., PMID:17714866

Characterization of a monoclonal antibody specific for human peripheral myelin protein 22 and its use in immunohistochemical studies of the fetal and adult nervous system., PMID:17374097

Dichloroacetate causes reversible demyelination in vitro: potential mechanism for its neuropathic effect., PMID:17241159

[Biochemical features of chronic inflammatory demyelinating polyradiculoneuropathy]., PMID:16585917

Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy., PMID:16519780

Guillain-Barré syndrome., PMID:16271648

Immunohistochemical staining of epoxy resin sections of peripheral nerve., PMID:16082259

Induction of interleukin-6 in dorsal root ganglion neurons after gradual elongation of rat sciatic nerve., PMID:15913608

Inflammatory demyelination in a patient with CMT1A., PMID:12929199

The peroxisomal membrane targeting elements of human peroxin 2 (PEX2)., PMID:12751901

Proliferation of Schwann cells and regulation of cyclin D1 expression in an animal model of Charcot-Marie-Tooth disease type 1A., PMID:11835311

Immunological study of hereditary motor and sensory neuropathy type 1a (HMSN1a)., PMID:11796774

Peripheral myelin protein 22 is a constituent of intercellular junctions in epithelia., PMID:11717414

Investigation of serum response to PMP22, connexin 32 and P(0) in inflammatory neuropathies., PMID:11438177

Variability in immunohistochemistries of IgM M-proteins binding to sulfated glucuronyl paragloboside., PMID:11438175

The AN2 protein is a novel marker for the Schwann cell lineage expressed by immature and nonmyelinating Schwann cells., PMID:11157078

Uncoupling of myelin assembly and schwann cell differentiation by transgenic overexpression of peripheral myelin protein 22., PMID:10818147

Density dependent regulation of human Schwann cell proliferation., PMID:10719358

Datasheet

Document Download

Anti-PMP22 Antibody (R2B93).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-PMP22 Antibody (R2B93) [RHF86901]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only